Eremid Genomic Services

Technology/Service ProviderPrivate Company
Kannapolis, North Carolina, United States
2022
Founded
10-50
Employees

About Eremid Genomic Services

Eremid®’s CLIA-certified CAP-accredited laboratory is dedicated to providing the highest quality clinical genomics services. With a broad range of sequencing technologies for both short-read and long-read sequencing, SNP arrays, and supporting expertise in extraction and bioinformatics, Eremid is able to provide full-service-solutions for all your research, LDT and personalized medicine genomics needs. CLIA-certified, Gene Titan TM workflows

Services

Laboratory and Biospecimen/Biomarker ServicesGenomics servicesNGSCLIA / CAP / GLP genomics labLDT developmentBiomarker and CDx development

Therapeutic areas

Experience & capabilities

Trial phases:Phase 1Phase 2Phase 3Phase 4
Products:GenomicsCompanion Diagnostics
Trial geography:North AmericaEuropeGlobal
Languages:EnglishFrench

Team

  • Julian AberyCBO
  • Amy BettsMarketingLinkedIn

Browse companies by location

Kannapolis, United StatesUnited States

Similar Technology/Service Provider companies in United States

1nHealth

Technology/Service Provider
Orlando, United States·10-50 employees

If you’ve ever lost sleep over delayed study enrollment, consider 1nHealth your new weighted blanket. 1nHealth fills studies through a simple philosophy: Don’t waste the power of…

26FIVE Global Lab

Technology/Service Provider
New York, United States·50-200 employees

Amplity Health

Technology/Service Provider
Yardley, United States·500-5,000 employees

Bios Health Group

Technology/Service Provider
Duluth, United States·1-10 employees

Leveraging over 30 years of experience working with large biopharma, emerging biotech, CROs, and healthcare companies, the strategic advisors, executives, and subject matter…

Block Clinical Inc.

Technology/Service Provider
San Diego, United States·10-50 employees

Block Clinical is intently focused on streamlining the myriad of logistics involved in traditional, virtual, and hybrid clinical trials. From globally integrated patient…